SCARB1 and neoplasm: Namely, since non-malignant tissue shows significantly lower expression of SR-B1 compared to malignant tissue, it is suggested that HDL particles can be used as drug delivery systems and can have beneficial effects not only on the restriction of tumor growth but also on reduction in chemotherapy-induced cytotoxicity [167].